Related Experiment Video
Updated: Jun 6, 2026
09:15
Stereological Estimation of Cholinergic Fiber Length in the Nucleus Basalis of Meynert of the Mouse Brain
Published on: February 5, 2020
The cholinergic system in aging and neuronal degeneration
Reinhard Schliebs1, Thomas Arendt
1Paul Flechsig Institute for Brain Research, University of Leipzig, D-04109 Leipzig, Germany. schre@medizin.uni-leipzig.de
Behavioural Brain Research
|December 15, 2010
Summary
Normal aging causes gradual cholinergic dysfunction, not significant cell loss. Alzheimer's disease involves severe cholinergic degeneration, while mild cognitive impairment shows functional loss, highlighting the cholinergic system's role in cognitive decline.
Area of Science:
- Neuroscience
- Aging Research
- Neurodegenerative Diseases
Background:
- The basal forebrain cholinergic complex is crucial for cognitive functions, projecting to the cortex and hippocampus.
- Aging is associated with cholinergic hypofunction, traditionally attributed to cell loss, but recent evidence suggests functional decline over cell death in normal aging.
- Pathological aging, particularly Alzheimer's disease (AD), involves significant cholinergic neuron degeneration.
Purpose of the Study:
- To review the role of the cholinergic system in normal and pathological aging, focusing on Alzheimer's disease.
- To explore the mechanisms underlying cholinergic dysfunction in aging and AD.
- To discuss potential therapeutic strategies targeting the cholinergic system in early AD and aging.
Main Methods:
- Literature review and synthesis of existing research on cholinergic system function in aging and neurodegenerative diseases.
- Analysis of studies differentiating between normal aging and pathological conditions like AD regarding cholinergic cell integrity and function.
- Examination of molecular mechanisms, including neurotrophic factors and receptor alterations, contributing to cholinergic dysfunction.
Main Results:
- Normal aging leads to gradual cholinergic functional loss via dendritic, synaptic, and axonal degeneration, not significant cell death.
- Alzheimer's disease (AD) is characterized by severe loss of cholinergic innervation, while Mild Cognitive Impairment (MCI) shows functional deficits without overt neurodegeneration.
- Dysregulation of neurotrophic factors (NGF, proNGF), acetylcholine metabolism, and receptor expression (muscarinic, nicotinic) contribute to cholinergic dysfunction.
- β-amyloid in AD can trigger cholinergic dysfunction through various pathways, including interaction with α7 nicotinic acetylcholine receptors and effects on NGF signaling and tau phosphorylation.
Conclusions:
- Cholinergic dysfunction plays a key role in cognitive impairments associated with aging and AD.
- Early therapeutic interventions targeting cholinergic and neurotrophic signaling may ameliorate deficits in early AD.
- Anti-amyloid strategies might also prevent age-associated cholinergic deficits and cognitive decline, suggesting a link between amyloid pathology and cholinergic system integrity.
More Related Videos
07:57An Alternative Approach to Study Primary Events in Neurodegeneration Using Ex Vivo Rat Brain Slices
Published on: April 11, 2018
14:57Preparation of Acute Hippocampal Slices from Rats and Transgenic Mice for the Study of Synaptic Alterations during Aging and Amyloid Pathology
Published on: March 23, 2011
Related Concept Videos
01:30Indirect-Acting Cholinergic Agonists: Pharmacological Actions
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
01:23Cholinergic Neurons: Neurotransmission
Cholinergic neurotransmission involves the synthesis and the release of acetylcholine (ACh) in order to transmit nerve impulses across the synapse. The process begins with the synthesis of acetyl CoA, a precursor for ACh, from ATP, acetate, and coenzyme A in the mitochondria. Choline, another vital precursor, is transported inside the neuron through choline transporters, including high-affinity choline transporter CHT1, low-affinity choline transporter CTL1, and lower-affinity choline...
01:26Aging
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:26Chemical Synapses
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
01:26Chemical Synapses
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...